Triple-Pathway Fat Loss. Maximum Metabolic Power.

🔬 Product Overview

Retatrutide is a cutting-edge triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors. This multifaceted approach offers unparalleled potential in weight loss and metabolic health research.

🚀 Key Benefits

• Triple Hormone Activation: Engages GLP-1, GIP, and glucagon receptors to synergistically enhance weight loss and metabolic regulation.
• Superior Weight Reduction: In a 48-week phase 2 study, participants experienced up to 24.2% body weight loss with 12 mg dosing, surpassing results from other treatments like Ozempic and Mounjaro citeturn0search0.
• Enhanced Metabolic Health: Demonstrated improvements in liver fat content and cardiometabolic markers, indicating broader health benefits citeturn0search11.
• Reduced Dosing Frequency: Due to its potency, one vial will last for 5+weeks, depending on the research protocol.

🧪 Composition

• Active Ingredient: Retatrutide
• Concentration: 10mg per vial
• Form: Lyophilized peptide powder

📦 Usage & Storage

• Intended Use: For research purposes only
• Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study period.

🧠 Why Retatrutide Stands Out

• More Effective: Achieves greater weight loss in a shorter time frame compared to GLP-1 mono-agonists and dual agonists.
• Comprehensive Approach: Addresses multiple pathways involved in weight regulation and metabolic health.
• Research-Backed: Supported by robust clinical data demonstrating its efficacy and potential benefits citeturn0search0.

🔥 Pioneering the Future of Weight Loss Research

Retatrutide represents a significant advancement in the field of metabolic research. Its unique triple-action mechanism offers a promising avenue for studies focused on obesity, type 2 diabetes, and related metabolic disorders.

🛒 Order your 10mg Retatrutide today for £200.00